Botox Treatments to Ease Bladder Problems in People with MS

There is a new research that demonstrated how Botox injections to the bladder may help relieve bladder problems usually experienced by people suffering form multiple sclerosis or MS. This research, which was funded by the MS Society of UK, was made at the National Hospital for Neurology and Neurosurgery in the UK.

In the said research study, 43 patients suffering from multiple sclerosis and who were also experiencing bladder problems were treated with botulinum neurotoxin type A bladder muscle injections. The said injections helped reduce involuntary contractions in the bladder and so helped in reducing the urgency and the frequency of urination in the test subjects.

Incontinence and other bladder problems are common for people who are suffering from multiple sclerosis. Usually the storage and the emptying processes involved in the bladder is disrupted and therefore is a cause for worry and distress for many multiple sclerosis sufferers. Not being able to "hold on" or urgency in urination is one of the troubling circumstances that MS sufferers find themselves in.

Botox injections in the bladder, as shown by the research has demonstrated how such a treatment may be able to provide significant improvements to incontinence as well as urgency problems that most MS sufferers may experience. The effect of the treatment was seen to last for 10 months and repeat treatments showed similar results.

According to Professor Clare Fowler, a consultant in Uro-Neurology at the National Hospital for Neurology and Neurosurgery, the study was a part of a research investigation and the said treatment is not yet widely available. The said treatment has not yet been licensed and it may take a few more years pending an ongoing study to further understand and verify treatment results.

The said study has been valuable in trying to search for ways as to why such treatments work so well. It also provides a possible treatment making use of a minimally invasive injection technique to people with MS who also suffer from bladder problems as an eventual result of the said disease. Time will tell if this new treatment will be able to become a standard care for people with MS who might need it. An improved bladder control may be able to help MS sufferers with bladder problems lead an improved quality of life.

Source: http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=2338&CFID=5181811&CFTOKEN=57428268

 
You can leave a response, or trackback from your own site.